The Increasing Financial Impact of Chronic Kidney Disease in Australia
The aim of this investigation was to determine and compare current and projected expenditure associated with chronic kidney disease (CKD), renal replacement therapy (RRT), and cardiovascular disease (CVD) in Australia. Data published by Australia and New Zealand Dialysis and Transplant Registry, Aus...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | International Journal of Nephrology |
| Online Access: | http://dx.doi.org/10.1155/2014/120537 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832553096424718336 |
|---|---|
| author | Patrick S. Tucker Michael I. Kingsley R. Hugh Morton Aaron T. Scanlan Vincent J. Dalbo |
| author_facet | Patrick S. Tucker Michael I. Kingsley R. Hugh Morton Aaron T. Scanlan Vincent J. Dalbo |
| author_sort | Patrick S. Tucker |
| collection | DOAJ |
| description | The aim of this investigation was to determine and compare current and projected expenditure associated with chronic kidney disease (CKD), renal replacement therapy (RRT), and cardiovascular disease (CVD) in Australia. Data published by Australia and New Zealand Dialysis and Transplant Registry, Australian Institute of Health and Welfare, and World Bank were used to compare CKD-, RRT-, and CVD-related expenditure and prevalence rates. Prevalence and expenditure predictions were made using a linear regression model. Direct statistical comparisons of rates of annual increase utilised indicator variables in combined regressions. Statistical significance was set at P<0.05. Dollar amounts were adjusted for inflation prior to analysis. Between 2012 and 2020, prevalence, per-patient expenditure, and total disease expenditure associated with CKD and RRT are estimated to increase significantly more rapidly than CVD. RRT prevalence is estimated to increase by 29%, compared to 7% in CVD. Average annual RRT per-patient expenditure is estimated to increase by 16%, compared to 8% in CVD. Total CKD- and RRT-related expenditure had been estimated to increase by 37%, compared to 14% in CVD. Per-patient, CKD produces a considerably greater financial impact on Australia’s healthcare system, compared to CVD. Research focusing on novel preventative/therapeutic interventions is warranted. |
| format | Article |
| id | doaj-art-fcabbf3a7cee484897795a9b516f46b6 |
| institution | Kabale University |
| issn | 2090-214X 2090-2158 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Nephrology |
| spelling | doaj-art-fcabbf3a7cee484897795a9b516f46b62025-02-03T05:57:08ZengWileyInternational Journal of Nephrology2090-214X2090-21582014-01-01201410.1155/2014/120537120537The Increasing Financial Impact of Chronic Kidney Disease in AustraliaPatrick S. Tucker0Michael I. Kingsley1R. Hugh Morton2Aaron T. Scanlan3Vincent J. Dalbo4Central Queensland University, Clinical Biochemistry Laboratory, School of Medical and Applied Sciences, Faculty of Sciences, Engineering and Health, Rockhampton, QLD 4702, AustraliaLa Trobe University, La Trobe Rural Health School, Faculty of Health Sciences, Bendigo, VIC 3550, AustraliaMassey University, School of Sport and Exercise, Palmerston North 4474, New ZealandCentral Queensland University, Clinical Biochemistry Laboratory, School of Medical and Applied Sciences, Faculty of Sciences, Engineering and Health, Rockhampton, QLD 4702, AustraliaCentral Queensland University, Clinical Biochemistry Laboratory, School of Medical and Applied Sciences, Faculty of Sciences, Engineering and Health, Rockhampton, QLD 4702, AustraliaThe aim of this investigation was to determine and compare current and projected expenditure associated with chronic kidney disease (CKD), renal replacement therapy (RRT), and cardiovascular disease (CVD) in Australia. Data published by Australia and New Zealand Dialysis and Transplant Registry, Australian Institute of Health and Welfare, and World Bank were used to compare CKD-, RRT-, and CVD-related expenditure and prevalence rates. Prevalence and expenditure predictions were made using a linear regression model. Direct statistical comparisons of rates of annual increase utilised indicator variables in combined regressions. Statistical significance was set at P<0.05. Dollar amounts were adjusted for inflation prior to analysis. Between 2012 and 2020, prevalence, per-patient expenditure, and total disease expenditure associated with CKD and RRT are estimated to increase significantly more rapidly than CVD. RRT prevalence is estimated to increase by 29%, compared to 7% in CVD. Average annual RRT per-patient expenditure is estimated to increase by 16%, compared to 8% in CVD. Total CKD- and RRT-related expenditure had been estimated to increase by 37%, compared to 14% in CVD. Per-patient, CKD produces a considerably greater financial impact on Australia’s healthcare system, compared to CVD. Research focusing on novel preventative/therapeutic interventions is warranted.http://dx.doi.org/10.1155/2014/120537 |
| spellingShingle | Patrick S. Tucker Michael I. Kingsley R. Hugh Morton Aaron T. Scanlan Vincent J. Dalbo The Increasing Financial Impact of Chronic Kidney Disease in Australia International Journal of Nephrology |
| title | The Increasing Financial Impact of Chronic Kidney Disease in Australia |
| title_full | The Increasing Financial Impact of Chronic Kidney Disease in Australia |
| title_fullStr | The Increasing Financial Impact of Chronic Kidney Disease in Australia |
| title_full_unstemmed | The Increasing Financial Impact of Chronic Kidney Disease in Australia |
| title_short | The Increasing Financial Impact of Chronic Kidney Disease in Australia |
| title_sort | increasing financial impact of chronic kidney disease in australia |
| url | http://dx.doi.org/10.1155/2014/120537 |
| work_keys_str_mv | AT patrickstucker theincreasingfinancialimpactofchronickidneydiseaseinaustralia AT michaelikingsley theincreasingfinancialimpactofchronickidneydiseaseinaustralia AT rhughmorton theincreasingfinancialimpactofchronickidneydiseaseinaustralia AT aarontscanlan theincreasingfinancialimpactofchronickidneydiseaseinaustralia AT vincentjdalbo theincreasingfinancialimpactofchronickidneydiseaseinaustralia AT patrickstucker increasingfinancialimpactofchronickidneydiseaseinaustralia AT michaelikingsley increasingfinancialimpactofchronickidneydiseaseinaustralia AT rhughmorton increasingfinancialimpactofchronickidneydiseaseinaustralia AT aarontscanlan increasingfinancialimpactofchronickidneydiseaseinaustralia AT vincentjdalbo increasingfinancialimpactofchronickidneydiseaseinaustralia |